UK Markets closed

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.58-0.02 (-0.36%)
At close: 4:00PM EDT
5.40 -0.18 (-3.23%)
After hours: 05:57PM EDT
Sign in to post a message.
  • F
    Frank
    loading zone here
  • Z
    Ziggy
    I first bought this in 1999. Prices are great now so just keep adding and adding. We should be back in the teens at some point. No rush. GLTA!
  • m
    marcos
    So Jeffries says if the drug is approved by the FDA there’s a chance of a 40% rise in stock price so a 6.50 stock up 40% is an additional 2.60 wow I hope the people who got in on the last offering are happy at when they purchased it at 11 and change
  • m
    marcos
    This is trading as if it missed its numbers for the past quarter which shouldn’t be a shock to anyone because this is exactly what this company does miss earnings delay trials oh and gorge on free stock options
  • O
    Oscar H.
    Eisai Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the companies have entered into an exclusive global strategic collaboration agreement for the co-development and co-commercialization of MORAb-202, an antibody drug conjugate (ADC). MORAb-202 is Eisai’s first ADC and combines Eisai’s in house developed anti-folate receptor alpha (FRα) antibody, and Eisai’s anticancer agent eribulin, using an enzyme cleavable linker. It is a potential best-in-class FRα ADC with a favorable pharmacology profile and demonstrated single agent activity in patients with advanced solid tumors.
  • J
    Jeff
    First of the month, let's issue some more shares to dilute our lack of earnings...
  • m
    marcos
    Well the good news is that it can only go to zero which at this rate will be by the end of August
  • H
    How
    By looking at MACD & RSI, we will pass pivot point of $6.79 next week. And after pass and stay above pivot point, R1 of $7.61 is next.
  • H
    How
    More than 10x average volumes of 1.7M traded already?
    We still got a few hours to go, so something is brewing here.
    The effects of delay submission from their announcement on their last earning is finally over.
    I think selling is overdone, and $6 is a strong support, those experience traders sees this too.
    Deep into oversold, with MACD is about to turn, I say load it up, today's volume speaks for itself.
  • J
    Jeff
    The only thing increasing are shares outstanding.

    200 million shares outstanding and increasing every month...

    OUCH!!!!!!

    Compare that to other cancer bios...

    Enough said...
  • F
    Frank
    just wait for the data
  • J
    Jeff
    Another 90k shares of dilution...

    Too many shares floating... she's toast...

    Most all other promising ADC and Cancer bio's floats are way more thinner. It's not even close...

    Market Cap, even here, way overvalued for revenue/products....
  • F
    Frank
    lots of loading going on
  • V
    V.
    IMGN is currently trading at a bargain price!
  • F
    Frank
    see everyone at 15 😎
  • m
    marcos
    The writing was on the wall when last week someone dumped a lot of shares this companies famous 4 words wait till next year
  • F
    Frank
    so wrong there
  • F
    Frank
    bottom basement prices here! back up the truck boys!
  • P
    PracticalWarlord
    I said it back in Feb. when it hit $10 and change that
    the trick top IMGN is to buy on around $5 and sell
    above $10.

    Some folks disagreed but here we go again!

    It's been doing that pattern the entire 21st century.